Miriam C. Sturkenboom, PharmD, PhD, FISPE

prof. dr.
University Medical Center Utrecht
Utrecht, Utrecht, Netherlands

AstraZeneca (Research Grant includes principal investigator, collaborator or consultant and pending grants as well as grants already received)European Medicines Agency (Research Grant includes principal investigator, collaborator or consultant and pending grants as well as grants already received)J&J (Research Grant includes principal investigator, collaborator or consultant and pending grants as well as grants already received)Pfizer (Research Grant includes principal investigator, collaborator or consultant and pending grants as well as grants already received)

Presentation(s):

• Updates from the COVID-19 Pharmacoepidemiological Battlefield: Recent Victories and Battles Ahead [Plenary]

  Saturday, August 27, 2022
  10:00 AM – 11:30 AM CEST

• COVID-19 Vaccine Safety Monitoring: Opportunities, Challenges and Lessons Learned for Pharmacoepidemiology

  Saturday, August 27, 2022
  4:15 PM – 5:45 PM CEST

• Myocarditis and Pericarditis Associated with SARS-CoV-2 Vaccines in Four European Countries Using Large Electronic Health Care Data Sources: A Population-based Descriptive Cohort and a Nested Self-controlled Risk Interval Study

  Sunday, August 28, 2022
  1:45 PM – 2:00 PM CEST